Wendy Komocsar

Eli Lilly (United States) — United States

Biochemistry, Genetics and Molecular Biology · Life Sciences

13h-index490citations51works2.72yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Inflammatory Bowel Disease(25), Microscopic Colitis(20), Monoclonal and Polyclonal Antibodies Research(13), Adolescent and Pediatric Healthcare(8), Rheumatoid Arthritis Research and Therapies(7)

Publications51 total

Efficacy and safety of mirikizumab in paediatric participants with moderately-to-severely active ulcerative colitis (SHINE-1): a multicentre, open-label, non-randomised phase 2 trial
˜The œLancet. Gastroenterology & hepatology·2025
Real-World Treatment Patterns Among Pediatric and Adult Patients with Crohn’s Disease in the United States
Drugs - Real World Outcomes·2025Open Access
Mirikizumab pharmacokinetics and exposure–response in pediatric patients with moderate‐to‐severe ulcerative colitis
CPT Pharmacometrics & Systems Pharmacology·2024· 3 citedOpen Access
Su1807 MIRIKIZUMAB PHARMACOKINETICS AND EXPOSURE-RESPONSE IN PEDIATRIC PATIENTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS: RESULTS FROM THE PHASE 2 SHINE-1 STUDY
Gastroenterology·2024
Su1808 MIRIKIZUMAB IMPROVED BOWEL URGENCY, ABDOMINAL PAIN, AND FATIGUE IN PEDIATRIC PATIENTS WITH MODERATE TO SEVERE ULCERATIVE COLITIS: FINAL RESULTS FROM THE PHASE 2 SHINE-1 STUDY
Gastroenterology·2024
Su1800 EFFICACY AND SAFETY OF MIRIKIZUMAB THERAPY IN PEDIATRIC PATIENTS WITH MODERATE TO SEVERE ULCERATIVE COLITIS: FINAL RESULTS FROM THE PHASE 2 SHINE-1 STUDY
Gastroenterology·2024
Drug hypersensitivity reactions: review of the state of the science for prediction and diagnosis
Toxicological Sciences·2024· 16 citedOpen Access
S1055 Burden of Bowel Urgency Among Pediatric Patients With Ulcerative Colitis: Results From a Physician and Patient Survey
The American Journal of Gastroenterology·2023
781 PK, EFFICACY AND SAFETY OF MIRIKIZUMAB AS INDUCTION THERAPY IN PEDIATRIC PATIENTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS: RESULTS FROM THE PHASE 2 SHINE-1 STUDY
Gastroenterology·2023· 4 citedOpen Access
Treatment and biologic maintenance-dosing patterns among pediatric patients with ulcerative colitis or Crohn’s disease
Current Medical Research and Opinion·2022
The Role of Master Protocols in Pediatric Drug Development
Therapeutic Innovation & Regulatory Science·2022· 13 citedOpen Access
Clinical Outcome Assessments in Pediatric Patients With Ulcerative Colitis and Crohn’s Disease Receiving Biologics: A Retrospective Cohort Study
Crohn s & Colitis 360·2022· 3 citedOpen Access
P110 Symptomology and most bothersome symptoms among pediatric Crohn’s disease and ulcerative colitis patients: Results from a physician and patient survey
Journal of Crohn s and Colitis·2021· 1 citedOpen Access
UNDERSTANDING REAL-WORLD BIOLOGIC MAINTENANCE DOSING PATTERNS AMONG PEDIATRIC ULCERATIVE COLITIS AND CROHN’S DISEASE PATIENTS
Gastroenterology·2021
DISEASE ACTIVITY, STERIOD-FREE REMISSION, AND CLINICAL OUTCOME ASSESSMENTS OF PEDIATRIC ULCERATIVE COLITIS AND CROHN’S DISEASE PATIENTS RECEIVING BIOLOGIC THERAPY
Gastroenterology·2021
TREATMENT PATTERNS OF NEWLY DIAGNOSED PEDIATRIC ULCERATIVE COLITIS AND CROHN’S DISEASE PATIENTS IN THE IMPROVECARENOW REGISTRY
Gastroenterology·2021
DISEASE ACTIVITY, STERIOD-FREE REMISSION, AND CLINICAL OUTCOME ASSESSMENTS OF PEDIATRIC ULCERATIVE COLITIS AND CROHN’S DISEASE PATIENTS RECEIVING BIOLOGIC THERAPY
Inflammatory Bowel Diseases·2021Open Access
TREATMENT PATTERNS OF NEWLY DIAGNOSED PEDIATRIC ULCERATIVE COLITIS AND CROHN’S DISEASE PATIENTS IN THE IMPROVECARENOW REGISTRY
Inflammatory Bowel Diseases·2021
UNDERSTANDING REAL-WORLD BIOLOGIC MAINTENANCE DOSING PATTERNS AMONG PEDIATRIC ULCERATIVE COLITIS AND CROHN’S DISEASE PATIENTS
Inflammatory Bowel Diseases·2021
A qualitative study exploring the health-related quality of life and symptomatic experiences of adults and adolescents with ulcerative colitis
Journal of Patient-Reported Outcomes·2019· 38 citedOpen Access
page 1 of 3Next →

Frequent Co-authors

Theresa Hunter(19), Wallace Crandall(14), April N. Naegeli(10), Amy Larkin(10), Jennifer L. Dotson(8), Richard B. Colletti(7), Steven J. Steiner(7), Keith Benkov(7), Nanhua Zhang(7), Melissa Veenhuizen(6), Pierre‐Yves Berclaz(6), Amy Larkin(6), Diana Stefani-Hunyady(6), Krista Schroeder(5), Anne Gill(5), Chin Lee(5), Jordan Johns(5), Chunyan Liu(5), Eric Nantz(4), Jess L. Kaplan(4)